Clinical Trials Logo

Esophageal Varices clinical trials

View clinical trials related to Esophageal Varices.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06017102 Recruiting - Esophageal Varices Clinical Trials

Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices

Start date: September 5, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the safeness and effectiveness of traditional esophagogastroduodenoscope (EGD) and wired magnetically assisted capsule endoscopy (MACE) in the diagnosis of esophageal varices in biliary atresia (BA) patients. The main questions it aims to answer are: - Subjects who do wired magnetically assisted capsule endoscopy do not need to open the mouths during the process, this study also want to know whether wired magnetically assisted capsule endoscopy can reduce the generation of droplets. - Diagnostic accuracy between traditional esophagogastroduodenoscope and wired magnetically assisted capsule endoscopy in biliary atresia patients with esophageal varices. Participants will do either traditional esophagogastroduodenoscope or wired magnetically assisted capsule endoscopy.

NCT ID: NCT04602663 Recruiting - Esophageal Varices Clinical Trials

Optimal Time for Follow up After Variceal Band Ligation

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Optimal time for follow up after variceal band ligation in cirrhotic patients remains to be determined

NCT ID: NCT04499898 Recruiting - Esophageal Varices Clinical Trials

Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding

Start date: October 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension

NCT ID: NCT04074473 Recruiting - Acute Kidney Injury Clinical Trials

Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varices

AKI
Start date: April 13, 2015
Phase: Phase 4
Study type: Interventional

We will include patients with EV and EVB. They will be randomized to EVL vs. NSBB for primary prevention And EVL+long-term NSBB vs. EVL+short-term NSBB for secondary prevention. 150 patients will be included in a 3-year period. Primary end-points are formation/progression of ascites, acute kidney injury and survival. The other outcomes such as bleeding, rebleeding, infection and other risk factors will be also analyzed.

NCT ID: NCT03989973 Recruiting - Liver Cirrhosis Clinical Trials

Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis

Start date: September 1, 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this retrospective study was to investigate the diagnostic performance of 2D-SWE for predicting the presence of esophageal varices and high-risk varices in patients with liver cirrhosis.

NCT ID: NCT03624517 Recruiting - Liver Cirrhoses Clinical Trials

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

LOVARB
Start date: September 19, 2018
Phase: Phase 4
Study type: Interventional

This study evaluates the safety and efficacy of 24-hour vs 72-hour octreotide infusion after variceal banding in cirrhotic patients with bleeding esophageal varices.

NCT ID: NCT03212872 Recruiting - Clinical trials for Chronic Liver Disease

Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding

EV
Start date: July 7, 2016
Phase: N/A
Study type: Interventional

Assessment of blood ammonia level as a non-invasive predictor for presence of EV and risk of bleeding

NCT ID: NCT02740166 Recruiting - Esophageal Varices Clinical Trials

Preventing Recurrent Bleeding After Eradication of Esophageal Varices

Start date: June 2013
Phase: Phase 4
Study type: Interventional

Esophageal variceal bleeding is a severe complication of portal hypertension. Banding ligation plus non-selective beta-blockers is the current recommendation for prevention of recurrent bleeding. However, the optimal duration of use of non-selective beta-blockers is not well defined. This study aims at comparing the rebleeding rate and adverse effects in patients using or without using propranolol after eradication of esophageal varices.